# DIBBS #SPE2DP-26-T-5238

DLA Solicitation for Atenolol Tablets, 25 mg, 100-count Bottles

**Posted:** September 25, 2026
**Respond By:** September 30, 2026
**Identifier:** SPE2DP-26-T-5238
**NAICS:** 424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is seeking Atenolol Tablets, 25 mg, in 100-count bottles for military medical supply.
- Government Buyer:
  - Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia
  - Contact: Imerah Burnett
- OEMs (Original Equipment Manufacturers):
  - McKesson Corporation (P/N 463649)
  - Teva Pharmaceuticals USA, Inc. (P/N NDC00093-0787-01)
  - Mylan Pharmaceuticals Inc. (P/N NDC00378-0218-01)
- Products Requested:
  - Atenolol Tablets, 25 mg, 100-count bottles
  - National Stock Number (NSN): 6505-01-336-6196
  - Total quantity: 3 bottles (1 bottle and 2 bottles in separate line items)
- Notable Requirements:
  - Delivery required within 20 days, FOB destination to specified military locations
  - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1
  - Only approved manufacturers and part numbers accepted
- No additional technical requirements or attachments beyond packaging/marking standards and approved sources

### Description

ATENOLOL TABLETS (QTY: 2, NSN: 6505-01-336-6196, Purchase Request: 7018471305)
  Approved Sources:
  - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION
  - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC
  - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.
 
ATENOLOL TABLETS (QTY: 1, NSN: 6505-01-336-6196, Purchase Request: 7018501837)
  Approved Sources:
  - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION
  - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC
  - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5238)
